Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Freed-Pastor is a medical oncologist and physician-scientist at the Dana-Farber Cancer Institute specializing in gastrointestinal cancers. Dr. Freed-Pastor received his M.D., Ph.D. from Columbia University College of Physicians and Surgeons. Following the successful completion of his MD/PhD, Dr. Freed-Pastor completed his residency training in Internal Medicine at Massachusetts General Hospital, followed by a Medical Oncology fellowship at the Dana-Farber Cancer Institute. Dr. Freed-Pastor also conducts research in the laboratory of Dr. Tyler Jacks at the Koch Institute for Integrative Cancer Research at MIT, one of the Lustgarten Foundation dedicated pancreatic cancer research laboratories. His research focuses on developing improved pre-clinical and co-clinical models for pancreatic cancer, with a particular emphasis on understanding the role of the immune system during pancreatic tumor development and offering insights into therapeutic approaches that leverage the immune system for the treatment of pancreatic cancer.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions